Photo via ABC News (US)

Some wellness peptides will become widely available, HHS says

Read the original at ABC News (US) ↗
Cite

Benadjaoud, Y. (2026, October 28). Some wellness peptides will become widely available, HHS says. ABC News (US). https://abcnews.com/Health/wellness-peptides-become-widely-hhs/story?id=137650076

Dated from the outlet's own feed. Check the original for its byline.

ABC News (US) · collected 2026-10-29 · by Youri Benadjaoud

Quick Summary

The Health and Human Services (HHS) announced on Wednesday that it will temporarily allow compounding pharmacies to produce six wellness peptides by prescription, including BPC-157 and TB-500. These peptides have been marketed online for various health benefits like tissue repair and skin improvement, though there is no clinical evidence supporting these claims. The HHS stated that this decision aims to provide patients with a regulated alternative to unregulated black-market products while emphasizing safety measures such as patient-specific prescriptions and quality testing requirements.
Written by AI on 2026-10-29, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

As of October 28, 2026, the Trump administration's Department of Health and Human Services (HHS) allowed pharmacies to produce and sell six unapproved peptide drugs without FDA approval. This decision faced significant opposition from most FDA scientific staff members who warned it could undermine public health by exposing Americans to potentially unsafe substances. HHS stated that this move is intended to provide a regulated alternative for consumers seeking peptides, which have previously been available through the "gray market," often imported illegally from countries like China. The policy will be in effect while HHS works on formalizing a rule change and is set to take comments for two weeks before finalization.

Written for “RFK Jr Eases Access To Unapproved Peptides” on 2026-11-04, grounded in this article and the 13 other(s) covering the same event.

Story

📰 RFK Jr Eases Access To Unapproved Peptides
Politics · 14 article(s) covering the same event. Compare every outlet's account →

Compared with similar articles

This article reads unscored and hedges 14% of its claims. Each row says how that neighbour differs.
ABC News (US)
Hedges 0 of 1 claims Outlet record 67/100
NBC News
Hedges 4 of 19 claims Outlet record 78/100
NPR
⚖️ Leans right Hedges 4 of 30 claims Outlet record 60/100
Reason
Hedges 5 of 23 claims Outlet record 67/100
New York Post
Hedges 6 of 46 claims Outlet record 66/100
TIME
Hedges 3 of 28 claims Outlet record 59/100
CBS News
⚖️ Centre Hedges 1 of 3 claims Outlet record 65/100
The Independent
Hedges 1 of 12 claims Outlet record 59/100
CBS News
Hedges 3 of 22 claims Outlet record 65/100
BBC News
⚖️ Leans right Hedges 1 of 20 claims Outlet record 66/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
14
sentences that state something as happening or true
Uncertain
14%
2 of 14 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
67/100
ABC News (US)'s corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
14
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-29 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

ABC News (US) · 1351 article(s) · 4 correction(s) detected
Running correction rate · 4 correction(s)

Who wrote this

Youri Benadjaoud
5 article(s) here · 1 carrying a prediction
🔮 Some wellness peptides will become widely available, HHS says "The policy does not ... establish clinical safety and effectiveness," HHS said.
🔮 Her last day will be Nov. 12, the CDC said.
🔮 We will continue to monitor the situation closely and adjust our public health response as conditions warrant.
Also by Youri Benadjaoud
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

FDA HHS The Health and Human Service epitalon semax

Subjects

HHS ORG · 5× FDA ORG · 4× Robert F. Kennedy Jr. PERSON · 1× The Health and Human Service ORG · 1× Trump PERSON · 1×

Narrative

It requires patient-specific prescriptions, traceable ingredients, quality testing, and safety reporting to hold compounders accountable and give patients an alternative to unregulated sellers." An independent FDA panel voted in July to recommend six peptides to the 503A bulks list, which are ingredients that compounding pharmacies can use for specialized or individualized prescriptions.
framing: assertive · carried by 1 article(s) · first seen 2026-10-29
🔮 Some wellness peptides will become widely available, HHS says "The policy does not ... establish clinical safety and effectiveness," HHS said.
2026-10-29 · ABC News (US)
Some wellness peptides will become widely available, HHS says · assertive framing

Claims (14 extracted, 2 hedged)

Some wellness peptides will become widely available, HHS says "The policy does not ... establish clinical safety and effectiveness," HHS said. asserted
HHS → become → safety
The Health and Human Service said Wednesday it will temporarily allow compounding pharmacies to make six peptides available by prescription. asserted
peptides → say → prescription
The peptides include BPC-157, TB-500, epitalon, MOTS-c, KPV and semax. asserted
peptides → include → BPC-157
The substances have been promoted online for anything from tissue repair to better skin. asserted
substances → promote → skin
Some also promote longevity, though scientific evidence on these claims remains unclear. uncertain
evidence → promote → claims
The HHS announcement cites safety and freedom as reasons for the decision. asserted
announcement → cite → decision
"Under President Trump’s leadership, HHS is working to put prevention and patient safety at the center of health care—and that includes confronting the risks of black-market peptides," the federal health agency said in a statement. asserted
agency → work → statement
"The policy does not grant FDA approval or establish clinical safety and effectiveness. asserted
policy → grant → safety
It requires patient-specific prescriptions, traceable ingredients, quality testing, and safety reporting to hold compounders accountable and give patients an alternative to unregulated sellers." An independent FDA panel voted in July to recommend six peptides to the 503A bulks list, which are ingredients that compounding pharmacies can use for specialized or individualized prescriptions. asserted
pharmacies → require → prescriptions
They can be synthesized such as medications like insulin and GLP-1 drugs, which have both been FDA approved for safety and efficacy following clinical trials. asserted
which → synthesize → trials
There are no published clinical trials that provide evidence that these specific peptides that became available today are effective in humans for any condition. asserted
that → be → condition
Doctors warn that these unregulated products may not be what is advertised and may be contaminated or inaccurately dosed. uncertain
what → warn → ?
In 2023, the FDA classified 19 peptides as unsafe to be compounded, a process where a specialized pharmacy mixing ingredients that are specific for a patient. asserted
that → classify → patient
HHS Secretary Robert F. Kennedy Jr. has previously claimed that action was illegal. asserted
action → claim → ?
💬Give feedback
🕘History 🎫Support